MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/gutjnl-2026-338462

Медицинская библиотека · Gut · 2026

Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

Xiang Yan-Jun, Liu Zong-Han, Feng Jin-Kai, Qin Ying-Yi, Yu Hong-Ming, Cheng Yu-Qiang, Chen Gang, Wu Jia-Yi, Zeng Yong-Yi, Tang Yu-Fu, Rao Jian-Hua, Zhang Feng-Min, Yang Shi-Ye, Wang Gui-Ran, Ye Lin-Sen, Lang Ren, Lin Jian-Hua, Zheng Yi-Tao, Mao Ye-Fan, Zhou Hong-Kun, Yan Mao-Lin, Liang Chao, Ren Si-Si, Wang Kang, Gong Lin, Xu Shuai, Xu Yun-Fei, Ni Qing-Qiang, Wang Kai, Fan Rui-Fang, Hu Yi-Lin, Jiang Tao, Lin Chao, Gao Qing-Lun, Wang Zhi-Qiang, Lu Yi-Meng, Zou Wen-Bo, Wang Xiao, Feng Chen, Wang Zi-Cheng, Liu Peng-Jiong, Wei Wen-Jing, Zhang Fan, Wu Wei, Lu Hao-Feng, Huang Jing-Yi, Liang Xin, Li Jing-Jing, Shan Yun-Feng, Zhang Xiu-Ping, Cheng Shu-Qun, Chinese Association of Liver Cancer and Chinese Medical Doctor Association

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Recurrence after curative-intent resection remains common in hepatocellular carcinoma (HCC), and whether postoperative incretin-based treatment choice influences outcomes in patients with type 2 diabetes (T2D) is unclear.

OBJECTIVE

To determine whether postoperative initiation of glucagon-like peptide-1 receptor agonists (GLP-1RAs), compared with dipeptidyl peptidase-4 inhibitors (DPP-4is), is associated with improved recurrence-free and overall survival after curative-intent resection for HCC.

DESIGN

Active-comparator, new-user target trial emulation using electronic medical records from 36 hospitals across China from 2014 to 2023, with follow-up through 1 October 2025. Eligible adults had histologically confirmed HCC and T2D, underwent R0 resection and initiated a GLP-1RA or DPP-4i within postoperative days 0 to 90. Time zero was the first qualifying prescription or order date. The primary estimand was intention-to-treat; a prespecified per-protocol analysis assessed sustained adherence. The primary outcome was recurrence-free survival (RFS), treating death without recurrence as a competing event; overall survival (OS) was secondary. The study was registered with the Chinese Clinical Trial Registry (ChiCTR2600118495).

RESULTS

Among 42 855 patients with HCC and T2D who underwent liver resection, 1249 were included in the final analytical cohort, including 723 DPP-4i initiators and 526 GLP-1RA initiators; median follow-up was 50.8 months. In weighted intention-to-treat analyses, GLP-1RA versus DPP-4i initiation was associated with longer RFS (cause-specific HR 0.80, 95% CI 0.67 to 0.96; p=0.016) and OS (HR 0.58, 95% CI 0.47 to 0.71; p<0.001). Per-protocol analyses were directionally consistent.

CONCLUSION

Postoperative GLP-1RA initiation, compared with DPP-4i initiation, was associated with delayed recurrence and longer OS; prospective confirmation is warranted.

TRIAL REGISTRATION NUMBER: ChiCTR2600118495.

Для цитирования: Xiang Yan-Jun, Liu Zong-Han, Feng Jin-Kai, Qin Ying-Yi, Yu Hong-Ming, Cheng Yu-Qiang, Chen Gang, Wu Jia-Yi, Zeng Yong-Yi, Tang Yu-Fu, Rao Jian-Hua, Zhang Feng-Min, Yang Shi-Ye, Wang Gui-Ran, Ye Lin-Sen, Lang Ren, Lin Jian-Hua, Zheng Yi-Tao, Mao Ye-Fan, Zhou Hong-Kun, Yan Mao-Lin, Liang Chao, Ren Si-Si, Wang Kang, Gong Lin, Xu Shuai, Xu Yun-Fei, Ni Qing-Qiang, Wang Kai, Fan Rui-Fang, Hu Yi-Lin, Jiang Tao, Lin Chao, Gao Qing-Lun, Wang Zhi-Qiang, Lu Yi-Meng, Zou Wen-Bo, Wang Xiao, Feng Chen, Wang Zi-Cheng, Liu Peng-Jiong, Wei Wen-Jing, Zhang Fan, Wu Wei, Lu Hao-Feng, Huang Jing-Yi, Liang Xin, Li Jing-Jing, Shan Yun-Feng, Zhang Xiu-Ping, Cheng Shu-Qun, Chinese Association of Liver Cancer and Chinese Medical Doctor Association. Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.. Gut. 2026. DOI: 10.1136/gutjnl-2026-338462.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.